Indian Pharmaceutical Industry: What’s Driving the Journey to USD 130 Billion?
As India targets a USD 130 billion pharmaceutical market by 2030, several key factors are expected to drive its next phase of growth.
As India targets a USD 130 billion pharmaceutical market by 2030, several key factors are expected to drive its next phase of growth.
Voy India, formerly EarlyFit, will initially focus on weight loss and obesity care before gradually expanding into broader therapeutic areas.
The proposed registry will initially focus on cardiac and orthopaedic implants and will expand gradually to include all implantable medical devices.
Invisalign maker Align Technology plans to invest around INR 1,900 crore in a new manufacturing facility in Hyderabad.
Lilly sees retatrutide as part of a broader portfolio approach to obesity care alongside its existing therapies Zepbound (tirzepatide) and Foundayo (orforglipron).
There are different types of lasers to address specific cosmetic and skin care needs. Let’s understand their uses and benefits.
The emerging healthcare centres in the tier II and tier III cities are helping improve accessibility and affordability to advanced treatments across the nation.
This article explores how personalized medicine and the application of AI optimise the management of chronic diseases like diabetes and heart disease.
The partnership aims to accelerate the development and dissemination of cutting-edge neurosurgical technologies, support global training and capacity-building initiatives.
The advanced technology will enable the delivery of modern radiotherapy techniques, strengthening cancer care services at the Army Hospital (R&R).